Your Organs.
In a Dish.
Patient-derived organoids recreate your unique biology for personalized drug testing, disease modeling, and treatment optimization. The future of medicine grows from your own cells.
The Living Medicine Platform
Organoids bridge the gap between laboratory research and human patients, providing unprecedented biological accuracy.
Patient-Derived Models
Create miniature organs from patient stem cells or biopsies, preserving individual genetic profiles for truly personalized medicine.
Drug Screening
Test thousands of drug candidates on patient-specific organoids before clinical trials, identifying responders and non-responders early.
Disease Modeling
Recapitulate complex diseases including cancer, cystic fibrosis, and neurodegenerative conditions in controlled laboratory environments.
Toxicity Prediction
Predict adverse drug reactions before human exposure using organ-specific toxicity assays that outperform animal models.
Biomarker Discovery
Identify novel biomarkers for disease progression and treatment response through multi-omics analysis of organoid cultures.
Clinical Integration
FDA-accepted New Approach Methodology (NAM) enabling direct translation from organoid results to clinical decision-making.
Multi-Organ Capability
From gut to brain, organoid technology spans the full spectrum of human organ systems.
Brain Organoids
Cerebral organoids model neural development, Alzheimer's, Parkinson's, and psychiatric disorders with tau pathology.
Lung Organoids
Airway and alveolar organoids for respiratory diseases, viral infections, and pulmonary drug delivery testing.
Cardiac Organoids
Beating heart organoids assess cardiotoxicity, arrhythmia risk, and cardiac regeneration therapies.
Kidney Organoids
Nephron-containing organoids model polycystic kidney disease, nephrotoxicity, and renal drug clearance.
Liver Organoids
Hepatic organoids predict drug metabolism, DILI risk, and model liver diseases including NASH and hepatitis.
Tumor Organoids
Patient-derived tumor organoids preserve cancer heterogeneity for personalized oncology drug screening.
Industry Landscape
Leading organizations advancing organoid technology for therapeutic applications.
?? Foundational Research
Build Your Organoid Program
Acquire organoids.app and lead the next generation of personalized medicine platforms.
Inquire About This Domain